The doses of these medications may need to be reduced when starting Ozempic
While both drug companies provide warning labels about common side effects of their GLP-1 medications, their labels may not provide adequate warning about severe complications such as stomach paralysis, intestinal blockages, or bowel obstruction
Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes
[18] [22] In December 2025, an oral version of semaglutide, sold under the brand name Wegovy, was approved in the US for weight management
Multiple endocrine neoplasia syndrome type 2 (MEN2): This rare genetic disorder increases the likelihood of thyroid cancer
Semaglutide GLP-1 has been highly successful in helping individuals achieve significant weight loss, with many clients experiencing transformative results that greatly enhance their quality of life